• News
  • Film and TV
  • Music
  • Tech
  • Features
  • Celebrity
  • Politics
  • Weird
  • Community
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • LADbible
  • SPORTbible
  • GAMINGbible
  • Tyla
  • UNILAD Tech
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
TikTok
YouTube
Submit Your Content
Doctor explains 'safety confusion' over Ozempic-like medication after conflicting studies released

Home> News> Health

Updated 12:55 9 May 2025 GMT+1Published 17:52 2 May 2025 GMT+1

Doctor explains 'safety confusion' over Ozempic-like medication after conflicting studies released

It follows the release of a ground-breaking Ozempic study

Ellie Kemp

Ellie Kemp

A popular diabetes drug that is often used for weight loss has shown potential to reverse liver damage in certain patients, a major new clinical trial has found.

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but people have been known to use it for weight loss purposes.

However, it could be massively beneficial for those with metabolic dysfunction-associated steatohepatitis (MASH) - a serious form of fatty liver disease.

Advert

In a 72-week clinical trial published April 30 in The New England Journal of Medicine, semaglutide was found to reduce liver fat, inflammation, and even improve scarring in MASH patients.

The drug - administered once a week via injection - could become only the second FDA-approved treatment for MASH.

In contrast, Pfizer announced it would stop developing danuglipron, an oral GLP-1 pill, after a participant in its trial showed signs of liver injury.

Advert

While the individual recovered quickly after stopping the medication, the company opted to scrap the product altogether.

Though both semaglutide and danuglipron belong to the GLP-1 receptor agonist family, it's the drug's chemistry that sees the products have such differing effects on patients - and their livers.

“It’s understandable that patients and the public might be confused by reports of vastly different safety profiles between drugs that appear to have similar effects,” Dr Suzanne Wylie, GP and medical adviser for IQdoctor, told UNILAD.

“Semaglutide and danuglipron are not the same drug - they may act on the same receptor, but differences in molecular structure, metabolism, and formulation can result in varied effects in the body, including how they are processed by the liver.”

Advert

Injectable semaglutide has shown liver health benefits in other patients too.

Pfizer scrapped its semaglutide pill after reports of a liver injury (Peter Dazeley/Getty Images)
Pfizer scrapped its semaglutide pill after reports of a liver injury (Peter Dazeley/Getty Images)

"In those with pre-existing liver conditions — such as non-alcoholic fatty liver disease (NAFLD), viral hepatitis, or cirrhosis — semaglutide has actually shown some promise in reducing liver fat and improving metabolic markers," Dr Wylie adds.

Ayesha Bashir, weight loss injection expert and prescribing pharmacist at Chemist4U, explained: "In people with non-alcoholic fatty liver disease (NAFLD), semaglutide not only reduced liver fat but also improved liver enzymes and other signs of metabolic health.

Advert

"This positive effect is likely because semaglutide helps the body use insulin better, reduces inflammation, and helps people lose weight, all of which are good for the liver."

"However, these benefits must be weighed carefully against the potential for liver stress in a compromised organ."

However, Danuglipron, an oral compound, is subject to 'first-pass metabolism', which could increase the liver’s exposure to toxic byproducts, Dr Wylie explains.

Bashir added: "Unlike semaglutide, it’s a different type of molecule and is taken by mouth, which means it passes through the liver before going anywhere else in the body.

Advert

Semaglutide can help reverse MASH, a liver condition (Sebastian Kaulitzki/Science Photo Library/Getty Images)
Semaglutide can help reverse MASH, a liver condition (Sebastian Kaulitzki/Science Photo Library/Getty Images)

"This can sometimes put extra stress on the liver, especially if the dose is increased quickly or if someone’s liver is more sensitive for genetic or other reasons."

“These findings highlight the importance of rigorous safety testing for all new agents, even those targeting well-established pathways,” Dr Wylie added.

Bashir added: "It’s also important to remember that not everyone reacts to medicines in the same way.

"Some people might have genes that make their liver process drugs differently, or they might have other health problems or lifestyle factors, like drinking alcohol or taking other medications, that make their liver more sensitive to new treatments."

With semaglutide now under review for expanded approval in MASH, this could be the start of reshaping the landscape of liver disease treatments.

Featured Image Credit: Iuliia Burmistrova/Getty Images

Topics: Ozempic, Health

Ellie Kemp
Ellie Kemp

Advert

Advert

Advert

Choose your content:

9 hours ago
10 hours ago
  • 9 hours ago

    Experts issue urgent warning against popular new tanning 'drug' that could cause brain swelling and cancer

    The viral trend promises to give users a natural glowing tan

    News
  • 10 hours ago

    Horrifying details emerge after plane carrying 200 passengers flies with no pilot after first officer collapsed

    The plane was diverted and thankfully all 200 passengers onboard landed safely.

    News
  • 10 hours ago

    Family win $100,000 in settlement after being accused of not paying $200 bill

    Peter and Ann McGirr were slammed in a Facebook post which falsely claimed they hadn't paid their bill

    News
  • 10 hours ago

    Chilling story of man who told family he was leaving with aliens and hasn't been seen since

    What happened to Granger Taylor has remained a mystery for 45 years

    News
  • Man who claimed he went blind after taking Ozempic takes company to court
  • Ozempic users report meat tasting like ‘barnyard’ as they lose desire for certain processed foods
  • Scientists discover worrying link between Ozempic-like drugs and mental health
  • Weight-loss jab study reveals shocking results of what happens to the body a year after coming off drug